Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study

CONCLUSIONS: Targeted DNA-based BM evaluated on routinely available FFPE samples improves prognostication of ACC beyond routinely available clinical and histopathological parameters. This approach may help to better individualise patient's management.PMID:37590967 | DOI:10.1093/ejendo/lvad112

Source: European Journal of Endocrinology - August 17, 2023 Category: Endocrinology Authors: Juliane Lippert Ulrich Dischinger Silke Appenzeller Alessandro Prete Stefan Kircher Kassiani Skordilis Yasir S Elhassan Barbara Altieri Martin Fassnacht Cristina L Ronchi Source Type: research